Cargando…
Commentary: A Review of Prognosis Model Associated With Cardiogenic Shock After Acute Myocardial Infarction
Autores principales: | Iborra-Egea, Oriol, García-García, Cosme, Bayés-Genís, Antoni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904737/ https://www.ncbi.nlm.nih.gov/pubmed/35282367 http://dx.doi.org/10.3389/fcvm.2022.856592 |
Ejemplares similares
-
Different Effects on Protein Expression of CDR132L, an Antisense Inhibitor of miR-132, and Standard Therapies for Myocardial Infarction
por: Iborra-Egea, Oriol, et al.
Publicado: (2022) -
Translational proteomics in cardiogenic shock: from benchmark to bedside
por: Iborra-Egea, Oriol, et al.
Publicado: (2022) -
The Potential Anti-remodeling Effect of Paroxetine After Myocardial Infarction May Be Blunted by Beta-Blockers
por: Iborra-Egea, Oriol, et al.
Publicado: (2022) -
A Review of Prognosis Model Associated With Cardiogenic Shock After Acute Myocardial Infarction
por: Wang, Jingyue, et al.
Publicado: (2021) -
A Risk Stratification Scheme for In-Hospital Cardiogenic Shock in Patients With Acute Myocardial Infarction
por: Yang, Jun-qing, et al.
Publicado: (2022)